Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.24 - $6.96 $15,214 - $47,272
-6,792 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$4.3 - $12.95 $8,419 - $25,356
-1,958 Reduced 22.38%
6,792 $43,000
Q4 2021

Feb 15, 2022

BUY
$10.0 - $16.78 $3,240 - $5,436
324 Added 3.85%
8,750 $97,000
Q3 2021

Nov 15, 2021

SELL
$15.58 - $22.88 $206,528 - $303,297
-13,256 Reduced 61.14%
8,426 $138,000
Q2 2021

Aug 16, 2021

BUY
$11.72 - $26.81 $142,655 - $326,331
12,172 Added 127.99%
21,682 $402,000
Q1 2021

May 18, 2021

BUY
$13.49 - $31.53 $15,000 - $35,061
1,112 Added 13.24%
9,510 $143,000
Q4 2020

Feb 16, 2021

BUY
$7.9 - $32.3 $66,344 - $271,255
8,398 New
8,398 $271,000

Others Institutions Holding CDAK

# of Institutions
1
Shares Held
238K
Call Options Held
0
Put Options Held
0

About Codiak BioSciences, Inc.


  • Ticker CDAK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,995,200
  • Market Cap $360K
  • Description
  • Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...
More about CDAK
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.